Latest stories on IPSC
Century Therapeutics Adds Director, Advances Cell Therapy Pipeline
TipRanks56 · neutralgeneral
Century Therapeutics, Inc. (IPSC) files 8-K
SEC 8-K50 · neutralgeneral
Century Therapeutics Appoints Joseph Truitt to Board of Directors
GlobeNewswire55 · neutralgeneral
Century Therapeutics Appoints Joseph Truitt to Board of Directors
Business Insider55 · neutralgeneral
Century Therapeutics Reports Q2 Results, Pipeline Advancements
TipRanks56 · neutralearnings
Century Therapeutics, Inc. (IPSC) files 8-K
SEC 8-K50 · neutralgeneral
Century Therapeutics GAAP EPS of -$0.17 misses by $0.05
Seeking Alpha34 · bearishearnings
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
StockTitan56 · neutralearnings
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire56 · neutralearnings
Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses
Yahoo Top63 · neutralproduct/pr
Century: 'Hold' Based On CNTY-101 Pivot And CNTY-813 T1D Curative Potential
Seeking Alpha45 · neutralanalyst
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
Business Insider67 · bullishproduct/pr
Century Therapeutics, Inc. (IPSC) files 8-K
SEC 8-K50 · neutralgeneral
Century Therapeutics, Inc. (IPSC) files 8-K
SEC 8-K50 · neutralgeneral
Century Therapeutics, Inc. (IPSC) Presents at American Diabetes Association (ADA) 86th Scientific Sessions - Slideshow
Seeking Alpha50 · neutralgeneral
Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy
TipRanks63 · neutralproduct/pr
Century Therapeutics, Inc. (IPSC) files 8-K
SEC 8-K50 · neutralgeneral
These healthcare stocks have maintained Strong Buy ratings for months
Seeking Alpha65 · bullishanalyst